SEC EDGAR · Company announcement
AMGN: Financial results
Filed 8-K for an event or period dated 2026-11-03. Financial results.
Follow AMGN- Became public
- Nov 3, 2026, 4:05 PM EST
- Event / period date
- Nov 3, 2026
- Collected
- Nov 7, 2026, 12:56 PM EST
Why this is connected
This filing identifies AMGEN INC as the issuer of the security. The company's SEC identifier connects it to AMGN.
Press Release dated November 3, 2026. ↗Source evidence
Read the source excerpt or record
Item 2.02 Results of Operations and Financial Condition. Third Quarter 2026 Earnings Press Release and Reconciliation of Non-GAAP Financial Measures On November 3, 2026 , the Company issued a press release announcing its unaudited results of operations for the three and nine months ended September 30, 2026, and its unaudited financial position as of September 30, 2026. The full text of the press release is furnished as Exhibit 99.1 hereto. In its press release the Company included certain non-U.S. Generally Accepted Accounting Principles (GAAP) financial measures as defined in Regulation G promulgated by the Securities and Exchange Commission. The non-GAAP financial measures included in the press release are non-GAAP earnings per share, non-GAAP operating income, non-GAAP operating margin, non-GAAP tax rate, non-GAAP operating expenses and sub-components of non-GAAP operating expenses such as non-GAAP cost of sales, non-GAAP research and development (R&D) expenses and non-GAAP selling, general and administrative expenses. Reconciliations for such non-GAAP financial measures to the most directly comparable GAAP financial measures are included in the press release. The Company included Free Cash Flow (FCF), which is computed by subtracting capital expenditures from operating cash flow, each as determined in accordance with GAAP. The Company believes that this presentation of non-GAAP financial measures provides useful supplementary information to, and facilitates additional analysis by, investors. The Company uses certain non-GAAP financial measures to enhance an investor’s overall understanding of the financial performance and prospects for the future of the Company’s ongoing business activities by facilitating comparisons of results of ongoing business operations among
Congressional trading in AMGN
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 2, 2026$15K–$50K
Sen. Sheldon Whitehouse (D-RI)
$15K–$50K · Traded Oct 15, 2026 · disclosed Nov 2, 2026 · Spouse
Committee overlap: Finance - Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 1, 2026$1K–$15K
Rep. David J. Taylor (R-OH-2)
$1K–$15K · Traded Sep 22, 2026 · disclosed Oct 1, 2026
- Sep 5, 2026$1K–$15K
- Sep 5, 2026$1K–$15K
- Sep 2, 2026$1K–$15K
Sen. Sheldon Whitehouse (D-RI)
$1K–$15K · Traded Aug 12, 2026 · disclosed Sep 2, 2026 · Spouse
Committee overlap: Finance - Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 12, 2026$1K–$15K
Rep. David J. Taylor (R-OH-2)
$1K–$15K · Traded Jun 5, 2026 · disclosed Jun 12, 2026
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.